Pharmaceuticals Wholesale and Distribution Market by Type, End-user and Geography - Forecast and Analysis 2023-2027

Published: Sep 2023 Pages: 159 SKU: IRTNTR70680

Pharmaceuticals Wholesale and Distribution Market 2023-2027

The pharmaceuticals wholesale and distribution market size is estimated to grow at a CAGR of 8.92% between 2022 and 2027. The market size is forecast to increase by USD 776.32 billion. The growth of the market depends on several factors such as increasing government initiatives for pharmaceutical products, increasing government initiatives for pharmaceutical products, and rising seaborne pharmaceutical transportation. Our report examines historic data from 2017 to 2021, besides analyzing the current market scenario.

This report extensively covers market segmentation by type (branded drugs and generic drugs), end-user (retail pharmacies, hospital pharmacies, and others), and geography (North America, Asia, Europe, and Rest of World (ROW)). It also includes an in-depth analysis of drivers, trends, and challenges. 

What will be the Size of the Pharmaceuticals Wholesale And Distribution Market During the Forecast Period?

Pharmaceuticals Wholesale and Distribution Market Forecast 2023-2027

To learn more about this report,  Request Free Sample

Pharmaceuticals Wholesale and Distribution Market Dynamic

Our researchers studied the data for years, with 2022 as the base year and 2023 as the estimated year, and presented the key drivers, trends, and challenges for the market. Although there has been a disruption in the growth of the market during the COVID-19 pandemic, a holistic analysis of drivers, trends, and challenges will help companies refine marketing strategies to gain a competitive advantage.    

Driver - Growing global pharmaceutical sales

The rising geriatric population and new product launches by pharmaceutical manufacturers are the significant factors driving market growth. By 2024, the global pharmaceutical market includes prescription drugs and over-the-counter drugs and is anticipated to experience significant growth, and sales are expected to reach USD 1.4 trillion. The incidence of chronic diseases and the requirement for enhanced medical assistance are increasing. There is a dire need for more cutting-edge equipment to effectively deal with the rising number of patients. As a result, there will be new developments in medical devices and efficient transportation solutions for devices and equipment in the healthcare industry.

Factors such as the increasing healthcare awareness and the growing medicinal knowledge among people with the help of the Internet are increasing the sales of over-the-counter drugs. Moreover, over-the-counter drug manufacturers are introducing specific medicines for treating minor ailments by understanding consumer requirements, which, in turn, enriches their sales. The growth in pharmaceutical sales is anticipated to accelerate the growth of the global pharmaceutical wholesale and distribution market during the forecast period.

Trends - Emergence of drones in pharmaceuticals wholesale and distribution

Drones refer to unmanned aerial vehicles (UAVs) that are remotely controlled by a drone pilot. The functions and applications of drones are rising beyond military use to the logistics sector, particularly for delivery operations in remote or rural areas. Also, it can overcome the difficulty of an inefficient road or railway infrastructure. They can deliver essential pharmaceutical supplies to hard-to-reach remote destinations. The increased use of drones for the delivery of healthcare supplies is expected to improve market opportunities for global pharmaceutical wholesale and distribution players.

In addition, the use of drones will also support logistics companies in customizing their supply chain model effectively based on real-time information received from UAVs. Therefore, the adoption of drones mainly to deliver essential pharmaceutical supplies such as pharmaceutical drugs and medicines will positively impact the growth of the global market in focus during the forecast period.

Challenge - Increased complexities due to time-bound deliveries and customization of supply chain

As customers prefer shorter lead times, selecting the right supply chain model is important and critical, whereas logistics companies seek to keep the operational cost as low as possible. For sustaining the physical and chemical properties of the products, healthcare supplies need special care and attention, specific packaging, and a customized supply chain. Logistics intricacies vary with infrastructure based on topography, technological advances, and region/country-specific regulations and policies. Moreover, customization of the supply chain is based on multiple parameters, such as freight rate, freight volume, distribution network complexity, the distance between the source and destination, and the criticality of the delivery. Pharmaceutical manufacturers must share adequate information for designing a supply chain model.

However, if pharmaceutical manufacturers are more concerned about sharing confidential data with logistics service providers, information sharing will be affected. Also, the difference between urban and rural areas in terms of infrastructure required for an efficient logistics network makes the designing of a supply chain model highly intricate. Such factors will limit the growth of the pharmaceutical wholesale and distribution market during the forecast period.

Pharmaceuticals Wholesale and Distribution Market Segmentation by Type, End-user and Geography

Type Segment Analysis:

The market share growth by branded segment will be significant during the forecast period. Branded drugs are medicines that are discovered and developed by pharmaceutical companies and they manufacture and finalize these drugs based on comprehensive research and development results. United States Food and Drug Administration (FDA) approves the drug based on the information provided by the pharmaceutical company on their dosage form, chemistry, safety, efficacy, manufacturing methodology, and labeling, as well as packaging.

Get a Customised Report as per your requirements for FREE!

The branded drugs segment was valued at USD 571.58 billion in 2017. The initial expenses incurred on the research and development of these drugs and their testing advance their selling price. These drugs are preferred over generic drugs by consumers as counterfeits of generic drugs are easily available in the market although their prices are high. Despite the unprecedented challenges faced by global organizations and pharmaceutical companies, the Center for Drug Evaluation and Research (CDER) approved 53 novel drugs, either as new molecular entities (NMEs) under New Drug Applications (NDAs) or as new therapeutic biologics under Biologics License Applications (BLAs) in 2020. For instance, new drugs approved by the US FDA are Novartis AGs Kisqali (ribociclib), F. Hoffmann-La Roche Ltd.s Ocrevus (ocrelizumab), and Veklury (remdesivir) injection. The global pharmaceutical wholesale and distribution market is anticipated to grow with such approval of new drugs during the forecast period.

End-user Segment Analysis:

Based on end-users, the market has been segmented into retail pharmacies, hospital pharmacies, and others. The retail pharmacies will account for the largest share of this segment.? In 2022, retail pharmacies had the largest share of the global pharmaceuticals wholesale and distribution market. Retail pharmacies are increasingly emphasizing automation and technology to streamline operations, lower errors, and improve customer service.  With greater convenience and accessibility, online and mobile app-based prescription ordering and refill services have become more common to customers. The retail pharmacy landscape is likely to continue to grow as new technologies are adopted, consumer anticipations change and healthcare needs evolve. Such factors will have a positive impact on the growth of the global market in focus during the forecast period. 

Regional Analysis

For more insights on the market share of various regions View PDF Sample now!

North America is estimated to contribute 48% to the growth by 2027. Technavio’s analysts have elaborately explained the regional trends, drivers, and challenges that are expected to shape the market during the forecast period. In North America, the pharmaceutical wholesale and distribution market is anticipated to experience significant growth. In North America, the US is the significant revenue contributor to the market, due to the presence of several existing companies in the country, such as AmerisourceBergen Corp. (AmerisourceBergen), Cardinal Health Inc. (Cardinal Health), and Dakota Drug.

Furthermore, factors such as the growing introduction of new branded pharmaceutical drugs in the market and the demand for FDA-approved generic medicines, especially from the geriatric population in the region, will improve the growth of the pharmaceutical wholesale and distribution market in the region during the forecast period. 

COVID Recovery Analysis:

Owing to the outbreak of COVID-19 in the region, the demand for pharmaceutical drugs increased significantly in 2020. However, the major growth in the demand for generic and branded medicines, which are effective in curing congestion and fever, has led pharmaceutical retailers to produce solutions to continue their supply of such medicines. Large-scale vaccination drives were initiated across the region, which led to the lifting of lockdown restrictions in 2022. The companies in the market in focus in the region have expanded their investments to improve their distribution and wholesale channels and are developing their partnerships to strengthen their positions in the market during the forecast period. 

Who are the Major Pharmaceuticals Wholesale and Distribution Market Companies?

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

A.F. Hauser Pharmaceutical Inc. - The company offers pharmaceuticals wholesale and distribution services that supply generic drugs with the highest quality, offering low prices, while never sacrificing a uniquely personal approach in servicing client accounts.

We also have detailed analyses of the market’s competitive landscape and offer information on 20 market companies, including:

A.F. Hauser Pharmaceutical Inc., Alfresa Holdings Corp., AmerisourceBergen Corp., Attain Med Inc., Cardinal Health Inc., China Resources Pharmaceutical Group Ltd., Dakota Drug Inc., FFF Enterprises Inc., J M Smith Corp., McKesson Corp., Medipal Holdings Corp., Medline Industries LP, Morris and Dickson Co. LLC, Mutual Drug, Owens and Minor Inc., PHOENIX Pharmahandel GmbH and Co KG, Shanghai Fosun Pharmaceutical Group Co. Ltd., Sinopharm Group Co. Ltd., SUZUKEN Co. Ltd., and The Cigna Group 

Technavio report provides an in-depth analysis of the market and its players through combined qualitative and quantitative data. The analysis classifies companies into categories based on their business approaches, including pure-play, category-focused, industry-focused, and diversified. Companies are specially categorized into dominant, leading, strong, tentative, and weak, based on their quantitative data analysis.  

Segment Overview

The pharmaceuticals wholesale and distribution market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

  • Type Outlook (USD Billion, 2017 - 2027)
    • Branded drugs
    • Generic drugs
  • End-user Outlook (USD Billion, 2017 - 2027)
    • Retail pharmacies
    • Hospital pharmacies
    • Others
  • Region Outlook (USD Billion, 2017 - 2027)
    • North America
      • The U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • ROW
      • Brazil
      • Argentina
      • Australia

Pharmaceuticals Wholesale And Distribution Market Scope

Report Coverage

Details

Page number

159

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 8.92%

Market growth 2023-2027

USD 776.32 billion

Market structure

Fragmented

YoY growth 2022-2023(%)

7.89

Regional analysis

North America, Asia, Europe, and Rest of World (ROW)

Performing market contribution

North America at 48%

Key countries

US, Canada, Germany, China, and Japan

Competitive landscape

 Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Key companies profiled

A.F. Hauser Pharmaceutical Inc., Alfresa Holdings Corp., AmerisourceBergen Corp., Attain Med Inc., Cardinal Health Inc., China Resources Pharmaceutical Group Ltd., Dakota Drug Inc., FFF Enterprises Inc., J M Smith Corp., McKesson Corp., Medipal Holdings Corp., Medline Industries LP, Morris and Dickson Co. LLC, Mutual Drug, Owens and Minor Inc., PHOENIX Pharmahandel GmbH and Co KG, Shanghai Fosun Pharmaceutical Group Co. Ltd., Sinopharm Group Co. Ltd., SUZUKEN Co. Ltd., and The Cigna Group

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. 

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request PDF sample

What are the Key Data Covered in this Pharmaceuticals Wholesale And Distribution Market Research Report? 

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the pharmaceuticals wholesale and distribution market between 2023 and 2027
  • Precise estimation of the pharmaceuticals wholesale and distribution market size and its contribution to the market in focus on the parent market
  • Accurate predictions about upcoming trends and changes in consumer behaviour
  • Growth of the market across North America, Asia, Europe, and the Rest of the World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of pharmaceuticals wholesale and distribution market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global pharmaceuticals wholesale and distribution market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on global pharmaceuticals wholesale and distribution market 2017 - 2021 ($ billion)
    • 4.2 Type Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – Type Segment 2017 - 2021 ($ billion)
    • 4.3 End-User Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – End-User Segment 2017 - 2021 ($ billion)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ billion)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ billion)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Type

    • 6.1 Market segments
      • Exhibit 30: Chart on Type - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
    • 6.2 Comparison by Type
      • Exhibit 32: Chart on Comparison by Type
      • Exhibit 33: Data Table on Comparison by Type
    • 6.3 Branded drugs - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Branded drugs - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 35: Data Table on Branded drugs - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 36: Chart on Branded drugs - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Branded drugs - Year-over-year growth 2022-2027 (%)
    • 6.4 Generic drugs - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Generic drugs - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 39: Data Table on Generic drugs - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 40: Chart on Generic drugs - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Generic drugs - Year-over-year growth 2022-2027 (%)
    • 6.5 Market opportunity by Type
      • Exhibit 42: Market opportunity by Type ($ billion)
      • Exhibit 43: Data Table on Market opportunity by Type ($ billion)

    7 Market Segmentation by End-user

    • 7.1 Market segments
      • Exhibit 44: Chart on End-user - Market share 2022-2027 (%)
      • Exhibit 45: Data Table on End-user - Market share 2022-2027 (%)
    • 7.2 Comparison by End-user
      • Exhibit 46: Chart on Comparison by End-user
      • Exhibit 47: Data Table on Comparison by End-user
    • 7.3 Retail pharmacies - Market size and forecast 2022-2027
      • Exhibit 48: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 49: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 50: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
      • Exhibit 51: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
    • 7.4 Hospital pharmacies - Market size and forecast 2022-2027
      • Exhibit 52: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 53: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 54: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
      • Exhibit 55: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
    • 7.5 Others - Market size and forecast 2022-2027
      • Exhibit 56: Chart on Others - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 57: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 58: Chart on Others - Year-over-year growth 2022-2027 (%)
      • Exhibit 59: Data Table on Others - Year-over-year growth 2022-2027 (%)
    • 7.6 Market opportunity by End-user
      • Exhibit 60: Market opportunity by End-user ($ billion)
      • Exhibit 61: Data Table on Market opportunity by End-user ($ billion)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 63: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 64: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 65: Chart on Geographic comparison
      • Exhibit 66: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Asia - Market size and forecast 2022-2027
      • Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.5 Europe - Market size and forecast 2022-2027
      • Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 China - Market size and forecast 2022-2027
      • Exhibit 87: Chart on China - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 88: Data Table on China - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 89: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 90: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.9 Canada - Market size and forecast 2022-2027
      • Exhibit 91: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 92: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 93: Chart on Canada - Year-over-year growth 2022-2027 (%)
      • Exhibit 94: Data Table on Canada - Year-over-year growth 2022-2027 (%)
    • 9.10 Japan - Market size and forecast 2022-2027
      • Exhibit 95: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 96: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 97: Chart on Japan - Year-over-year growth 2022-2027 (%)
      • Exhibit 98: Data Table on Japan - Year-over-year growth 2022-2027 (%)
    • 9.11 Germany - Market size and forecast 2022-2027
      • Exhibit 99: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 100: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 103: Market opportunity by geography ($ billion)
      • Exhibit 104: Data Tables on Market opportunity by geography ($ billion)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 105: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 107: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 108: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 109: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 110: Matrix on vendor position and classification
            • 12.3 A.F. Hauser Pharmaceutical Inc.
              • Exhibit 111: A.F. Hauser Pharmaceutical Inc. - Overview
              • Exhibit 112: A.F. Hauser Pharmaceutical Inc. - Product / Service
              • Exhibit 113: A.F. Hauser Pharmaceutical Inc. - Key offerings
            • 12.4 Alfresa Holdings Corp.
              • Exhibit 114: Alfresa Holdings Corp. - Overview
              • Exhibit 115: Alfresa Holdings Corp. - Business segments
              • Exhibit 116: Alfresa Holdings Corp. - Key news
              • Exhibit 117: Alfresa Holdings Corp. - Key offerings
              • Exhibit 118: Alfresa Holdings Corp. - Segment focus
            • 12.5 AmerisourceBergen Corp.
              • Exhibit 119: AmerisourceBergen Corp. - Overview
              • Exhibit 120: AmerisourceBergen Corp. - Business segments
              • Exhibit 121: AmerisourceBergen Corp. - Key offerings
              • Exhibit 122: AmerisourceBergen Corp. - Segment focus
            • 12.6 Attain Med Inc.
              • Exhibit 123: Attain Med Inc. - Overview
              • Exhibit 124: Attain Med Inc. - Product / Service
              • Exhibit 125: Attain Med Inc. - Key offerings
            • 12.7 Cardinal Health Inc.
              • Exhibit 126: Cardinal Health Inc. - Overview
              • Exhibit 127: Cardinal Health Inc. - Business segments
              • Exhibit 128: Cardinal Health Inc. - Key news
              • Exhibit 129: Cardinal Health Inc. - Key offerings
              • Exhibit 130: Cardinal Health Inc. - Segment focus
            • 12.8 China Resources Pharmaceutical Group Ltd.
              • Exhibit 131: China Resources Pharmaceutical Group Ltd. - Overview
              • Exhibit 132: China Resources Pharmaceutical Group Ltd. - Product / Service
              • Exhibit 133: China Resources Pharmaceutical Group Ltd. - Key offerings
            • 12.9 Dakota Drug Inc.
              • Exhibit 134: Dakota Drug Inc. - Overview
              • Exhibit 135: Dakota Drug Inc. - Product / Service
              • Exhibit 136: Dakota Drug Inc. - Key offerings
            • 12.10 FFF Enterprises Inc.
              • Exhibit 137: FFF Enterprises Inc. - Overview
              • Exhibit 138: FFF Enterprises Inc. - Product / Service
              • Exhibit 139: FFF Enterprises Inc. - Key offerings
            • 12.11 J M Smith Corp.
              • Exhibit 140: J M Smith Corp. - Overview
              • Exhibit 141: J M Smith Corp. - Product / Service
              • Exhibit 142: J M Smith Corp. - Key offerings
            • 12.12 McKesson Corp.
              • Exhibit 143: McKesson Corp. - Overview
              • Exhibit 144: McKesson Corp. - Business segments
              • Exhibit 145: McKesson Corp. - Key offerings
              • Exhibit 146: McKesson Corp. - Segment focus
            • 12.13 Medline Industries LP
              • Exhibit 147: Medline Industries LP - Overview
              • Exhibit 148: Medline Industries LP - Product / Service
              • Exhibit 149: Medline Industries LP - Key offerings
            • 12.14 Owens and Minor Inc.
              • Exhibit 150: Owens and Minor Inc. - Overview
              • Exhibit 151: Owens and Minor Inc. - Business segments
              • Exhibit 152: Owens and Minor Inc. - Key offerings
              • Exhibit 153: Owens and Minor Inc. - Segment focus
            • 12.15 PHOENIX Pharmahandel GmbH and Co KG
              • Exhibit 154: PHOENIX Pharmahandel GmbH and Co KG - Overview
              • Exhibit 155: PHOENIX Pharmahandel GmbH and Co KG - Product / Service
              • Exhibit 156: PHOENIX Pharmahandel GmbH and Co KG - Key news
              • Exhibit 157: PHOENIX Pharmahandel GmbH and Co KG - Key offerings
            • 12.16 Shanghai Fosun Pharmaceutical Group Co. Ltd.
              • Exhibit 158: Shanghai Fosun Pharmaceutical Group Co. Ltd. - Overview
              • Exhibit 159: Shanghai Fosun Pharmaceutical Group Co. Ltd. - Business segments
              • Exhibit 160: Shanghai Fosun Pharmaceutical Group Co. Ltd. - Key offerings
              • Exhibit 161: Shanghai Fosun Pharmaceutical Group Co. Ltd. - Segment focus
            • 12.17 SUZUKEN Co. Ltd.
              • Exhibit 162: SUZUKEN Co. Ltd. - Overview
              • Exhibit 163: SUZUKEN Co. Ltd. - Business segments
              • Exhibit 164: SUZUKEN Co. Ltd. - Key offerings
              • Exhibit 165: SUZUKEN Co. Ltd. - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 166: Inclusions checklist
                • Exhibit 167: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 168: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 169: Research methodology
                • Exhibit 170: Validation techniques employed for market sizing
                • Exhibit 171: Information sources
              • 13.5 List of abbreviations
                • Exhibit 172: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              pharmaceuticals wholesale and distribution market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis